Prioritising the values of potential users to promote uptake of HIV pre-exposure prophylaxis

被引:1
|
作者
Traeger, Michael W. [1 ,2 ,3 ,4 ]
Krakower, Douglas S. [1 ,2 ,3 ,5 ]
Mayer, Kenneth H. [1 ,2 ,3 ,5 ]
Marcus, Julia L. [1 ,2 ]
机构
[1] Harvard Med Sch, Dept Populat Med, Boston, MA 02215 USA
[2] Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA
[3] Fenway Hlth, Fenway Inst, Boston, MA USA
[4] Burnet Inst, Melbourne, Vic, Australia
[5] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA USA
来源
LANCET HIV | 2023年 / 10卷 / 10期
关键词
D O I
10.1016/S2352-3018(23)00171-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Benefits of pre-exposure prophylaxis (PrEP) extend beyond HIV risk reduction. Users report a range of physical, emotional, and social effects, including reduced anxiety, increased intimacy, and greater sexual satisfaction. For some people, these benefits are the primary motivation for using PrEP. To successfully engage in shared decision making about HIV prevention methods, clinicians need to be able to discuss all potential risks and benefits of PrEP. These risks and benefits include not only those related to HIV risk reduction and other clinical outcomes, but also those related to experiences and relationships that people value. However, national and international clinical resources on the provision of PrEP do not include user-reported outcomes that are values-based or reflect positive effects on personal, social, or sexual wellbeing. To better integrate the values of potential users into discussions about PrEP, clinician training programmes and clinical guidelines need to be guided by community-driven frameworks and expanded to include user-reported outcomes of PrEP use, including beneficial effects. Achieving PrEP uptake and equity goals will require an approach to PrEP provision that centres the values and desired experiences of potential users, particularly those from populations with the greatest unmet need for PrEP.
引用
收藏
页码:e690 / e692
页数:3
相关论文
共 50 条
  • [1] Exploring factors hindering the uptake of HIV pre-exposure prophylaxis by potential users in Namibia
    Ashipala, Daniel O.
    SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2024, 25 (01)
  • [2] Online Prescriptions to HIV Pre-Exposure Prophylaxis and Pre-Exposure Prophylaxis Uptake
    Wille, Lexie
    Parent, Mike C.
    AIDS PATIENT CARE AND STDS, 2020, 34 (12) : 499 - 501
  • [3] HIV pre-exposure prophylaxis in injecting drug users
    Karim, Salim S. Abdool
    LANCET, 2013, 381 (9883): : 2060 - 2062
  • [4] Why Do HIV Pre-Exposure Prophylaxis Users Discontinue Pre-Exposure Prophylaxis Care? A Mixed Methods Survey in a Pre-Exposure Prophylaxis Clinic in Belgium
    Vanbaelen, Thibaut
    Rotsaert, Anke
    Jacobs, Bart K. M.
    Florence, Eric
    Kenyon, Chris
    Vuylsteke, Bea
    Laga, Marie
    Thijs, Reyniers
    AIDS PATIENT CARE AND STDS, 2022, 36 (04) : 159 - 167
  • [5] Users' expectations of the new pre-exposure prophylaxis for the HIV modalities
    de Jesus, Monica Lima
    Vargas, Maricelly Gomez
    Iniguez-Rueda, Lupicinio
    Fernandez-Gonzalez, Emmanuelle
    da Silva, Luis Augusto Vasconcelos
    Cabrera, Jose Miguel
    Perez, Felix
    Saz, Jorge
    CIENCIA & SAUDE COLETIVA, 2024, 29 (06):
  • [6] HIV pre-exposure prophylaxis (PrEP) uptake among alcohol users in rural South Africa
    Grammatico, M.
    Moll, A.
    Choi, K.
    Springer, S.
    Shenoi, S.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24
  • [7] HIV pre-exposure prophylaxis
    Sharma, Malika
    Tan, Darrell H. S.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (15) : E588 - E588
  • [8] HIV: Pre-exposure Prophylaxis
    Singh, Ajai Kumar
    Singh, Ashish
    Singh, Deepti
    Singh, Manish
    Singh, Pratibha
    Sharma, Abhishek
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2012, 3 (12) : 900 - 901
  • [9] HIV pre-exposure prophylaxis
    Fougere, Edouard
    ACTUALITES PHARMACEUTIQUES, 2024, 63 (638): : 14 - 16
  • [10] HIV pre-exposure prophylaxis
    Morin, Stephen F.
    Yamey, Gavin
    Rutherford, George W.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 345